No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Nikon introduces the ECLIPSE Ni-L Upright Microscope

Editor: What To Know

  • LED light sources boast a lifespan of approximately 25 times greater*1 than that of halogen light sources, contributing to the reduction of waste materials associated with replacement.
  • As commonly used brightfield microscopes transition away from halogen bulbs to LED light sources, this gives rise to images with blueish hues due to the unnatural color temperatures of many LED light sources.
  • This results in more accurate displays of the original color rendition of the specimen, making it particularly effective for the observation of pathological specimens and cells.

Nikon Instruments Inc. announced the release of the ECLIPSE Ni-L upright microscope which features specially balanced LED illumination with properties similar to natural light. This results in more accurate displays of the original color rendition of the specimen, making it particularly effective for the observation of pathological specimens and cells.

Release Overview

Product Name

ECLIPSE Ni-L Upright Microscope

Target Release Date

May 23, 2023

Development Background

HE-stained image of human histopathological tissue acquired using the ECLIPSE Ni-L and Digital Sight 10 microscope digital camera.

As commonly used brightfield microscopes transition away from halogen bulbs to LED light sources, this gives rise to images with blueish hues due to the unnatural color temperatures of many LED light sources. Nikon has developed the ECLIPSE Ni-L upright microscope equipped with a more balanced natural color LED light source that renders truer microscope images.

Main Features

1.  High color reproducibility by the adoption of high color-rendering LEDs

Since the color of LED light is stable, color information and images can be achieved with high color reproducibility when imaging specimens using microscope digital cameras and NIS-Elements imaging software. This reduces the need to correct color by color management software and contributes to improved accuracy of image analysis and AI learning.

2.Significant reduction in environmental impact

LED light sources boast a lifespan of approximately 25 times greater*1 than that of halogen light sources, contributing to the reduction of waste materials associated with replacement. Their low power consumption also contributes to the reduction of CO2 emissions within our environment. LED light sources also significantly reduce the maintenance load in terms of light source replacement and potential downtime.
*1 Approx. 50,000 hours, estimated by Nikon standards

3. Eliminates the need to utilize color balance filters

For microscopes using a halogen light source, color adjustments are made using NCB (Neutral Color Balance) filters to correct for the varied color temperatures normally experienced with this technology. Color balanced natural light LEDs eliminate the need to use these filters and therefore also eliminate the risk of human error, such as forgetting to attach or detach color correction filters during critical imaging sessions.

4.Space-saving compact design

Microscopes using a halogen light source are designed with externally attached lamp housings in order to facilitate regular light source replacement. The ECLIPSE Ni-L, due to longer life expectancy of LED light sources, has the illumination built-in resulting in an overall size reduction of 150 mm. This increases the flexibility to choose the most effective observation location to suit your needs.

Main Specifications

Optical system

CFI60 infinity optical system

Illumination

Built-in high  color-rendering LED light source*2    50,000 hours of life*3

Eyepieces

CFI 10X  CFI 12.5X

CFI 15X  CFI UW 10X

Tubes

Ergonomic binocular tube: Inclination angle 10° to 30°, extension up to 40 mm
Binocular tube
Trinocular tube

Nosepieces

Manual/motorized nosepieces

Stages

Manual stages

Condensers

Manual condensers

Observation method

Brightfield, epi-fluorescence, phase contrast, differential interference contrast, simple polarization, sensitive color polarization, darkfield

Weight

20 kg

Dimensions (mm)

W 320 x H 492 x D 383 (brightfield configuration with ergonomic binocular tube)

*2 Cannot be used for IR-DIC observation
*3 Estimated value based on Nikon standards

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy